MaxCyte News

Vicore Expands and Strengthens Its Board of Directors

STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of

Accesswire25minutes ago

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 12 20:19

Earnings Call Summary | MaxCyte(MXCT.US) Q1 2024 Earnings Conference

The following is a summary of the MaxCyte, Inc. (MXCT) Q1 2024 Earnings Call Transcript:Financial Performance:MaxCyte reported a total revenue of $11.3 million in Q1 2024, a rise of 32% from the $8.6

Futu NewsMay 11 22:24 · Conference Call

MaxCyte, Inc. (MXCT) Q1 2024 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 11 20:35

MaxCyte Shares Rise Sharply After Q1 Results Beat

MaxCyte (MXCT) shares were up more than 20% in recent Wednesday trading after the company reported better-than-expected Q1 results in the previous day. The company reported late Tuesday a Q1 loss of $

MT NewswiresMay 9 02:39

Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue guidance below estim

BenzingaMay 9 01:38

MaxCyte Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

MaxCyte Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BenzingaMay 9 01:18

ISUN, DTCK and MXCT Among Mid-day Movers

Seeking AlphaMay 9 00:52

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersMaxCyte (NASDAQ:MXCT) shares rose 26.5% to $4.97 during Wednesday's regular session. The company's market cap stands at $519.4 million. The company's, Q1 earnings came out yesterday. Elanco Ani

BenzingaMay 9 00:31

MaxCyte Up Over 27%, on Track for Record Percent Increase -- Data Talk

MaxCyte, Inc. (MXCT) is currently at $5.00, up $1.07 or 27.23% --Would be highest close since Feb. 2, 2024, when it closed at $5.15 --Would be largest percent increase on record (Based on available

Dow JonesMay 8 23:31

Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were mixed, with the Dow Jones gaining around 70 points on Wednesday.Shares of Louisiana-Pacific Corporation (NYSE:LPX) rose sharply during Wednesday's session following better-than-expec

BenzingaMay 8 23:11

Tivic Health Systems, NewGenIvf Group, Elanco Animal Health Among Healthcare Movers

Seeking AlphaMay 8 22:00

Q1 2024 MaxCyte Inc Earnings Call

Yahoo FinanceMay 8 18:35

MaxCyte Inc (MXCT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...

Yahoo FinanceMay 8 15:58

MaxCyte Q1 Earnings Surge With SPL Program Success

TipRanksMay 8 14:56

MaxCyte Files Q1 2024 Financials With SEC

TipRanksMay 8 14:52

Earnings Flash (MXCT.L) MAXCYTE Posts Q1 Revenue $11.3M

02:03 AM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (MXCT.L) MAXCYTE Posts Q1 Revenue $11.3M

MT NewswiresMay 8 14:03

Earnings Flash (MXCT.L) MAXCYTE Reports Q1 Loss $-0.09

02:03 AM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (MXCT.L) MAXCYTE Reports Q1 Loss $-0.09

MT NewswiresMay 8 14:03

MaxCyte Affirms 2024 Revenue Guidance For Core Business Revenue To Be Flat To 5% Growth

MaxCyte expects to end 2024 with at least $175 million in total cash, cash equivalents and investments.

BenzingaMay 8 05:24

MaxCyte | 10-Q: Quarterly report

Futu NewsMay 8 05:07 · Announcements